Virgin and Fremont receive $3.5 million for their work on norovirus. An additional $570K is awarded to Amarasinghe and Ellebedy in separate grants.
Gaya Amarasinghe, PhD, Associate Professor of Pathology & Immunology, of Biochemistry and Molecular Biophysics, and of Molecular Microbiology, with Dr. Christopher Basler, PhD, Professor and Director, Center for Microbial Pathogenesis, Georgia Research Alliance Eminent Scholar in Virology, Institute for Biomedical Sciences, Georgia State University, received a one-year $533,763 grant from the National Institutes of Health, entitled “Development, Validation and Optimization of HTS Screens Targeting Nipah and Hendra Virus RNA Synthesis”.
Ali Ellebedy, PhD, Assistant Professor, Pathology & Immunology, received a one-year $38,125 grant from the Clinical and Translational Science Awards, entitled “Interrogation of human B cell responses following influenza virus infection and vaccination”.
Herbert Virgin IV, MD, PhD, Edward Mallinckrodt Professor and Chair, Pathology & Immunology, Professor of Molecular Microbiology and of Medicine, with Daved Fremont, PhD, Professor of Pathology & Immunology, of Biochemistry and Molecular Biophysics, and of Molecular Microbiology, received a five-year $3,499,370 grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, entitled “The Role of CD300 Family in Norovirus Tropism, Persistence, and Immunity”.